(Q46488605)

22 December 2017

title

High glucose reduces cathepsin L activity and impairs invasion of circulating progenitor cells (English)

1 reference

22 December 2017

author

Stefanie Dimmeler

5

1 reference

22 December 2017

Carmen Urbich

1

object named as

Carmen Urbich

1 reference

22 December 2017

Andreas Zeiher

4

object named as

Andreas M Zeiher

1 reference

22 December 2017

Lothar Rössig

3

object named as

Lothar Rössig

1 reference

22 December 2017

author name string

Elisabeth Dernbach

2

1 reference

22 December 2017

publication date

21 June 2008

1 reference

22 December 2017

Journal of Molecular and Cellular Cardiology

published in

1 reference

22 December 2017

volume

45

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

429-436

1 reference

22 December 2017

Isolation of putative progenitor endothelial cells for angiogenesis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Transcoronary transplantation of progenitor cells after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Pericellular proteases in angiogenesis and vasculogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Matrix metalloproteinases and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Cathepsin L is required for endothelial progenitor cell-induced neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Invasion of melanoma cells into dermal connective tissue in vitro: evidence for an important role of cysteine proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Secreted cathepsin L generates endostatin from collagen XVIII

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Invariant chain controls the activity of extracellular cathepsin L.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Sequential analysis of N- and O-linked glycosylation of 2D-PAGE separated glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Cathepsin B and L are involved in degradation of prions in GT1-1 neuronal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

p38 mitogen-activated protein kinase downregulates endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

The functions of thrombospondin-1 and-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

Proteolysis of thrombospondin during cathepsin-G-induced platelet aggregation: functional role of the 165-kDa carboxy-terminal fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.06.004

10.1016/J.YJMCC.2008.06.004

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017